Back
Arbutus Biopharma Vs. Ionis Pharmaceuticals Industry Stock Comparison
Sell
37
ABUS
Arbutus Biopharma
Last Price:
3.41
Seasonality Move:
24.22%
Sell
39
IONS
Ionis Pharmaceuticals
Last Price:
35.37
Seasonality Move:
4.86%
Sell
37
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
- The current Arbutus Biopharma [ABUS] share price is $3.41. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Ionis Pharmaceuticals (IONS)
is a Sell
Is Ionis Pharmaceuticals a Buy, Sell or Hold?
- The current Ionis Pharmaceuticals [IONS] share price is $35.37. The Score for IONS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- IONS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight selling pressure.
IONS Stock Price Chart
What is Ionis Pharmaceuticals's stock price today?
-
The Ionis Pharmaceuticals share price today is $35.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IONS is experiencing slight selling pressure.
ABUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 30.86 | Sell |
| Chaikin Money Flow: | -303520 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.53 - 3.97) | Sell |
| Bollinger Bands (100): | (3.59 - 4.11) | Sell |
IONS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.31 | Sell |
| Relative Strength Index (14 RSI): | 41.39 | Sell |
| Chaikin Money Flow: | -380531 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.28 - 39.48) | Sell |
| Bollinger Bands (100): | (37.98 - 48.12) | Sell |
ABUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.49 | Sell |
| 20-day SMA: | 3.68 | Sell |
| 50-day SMA: | 3.85 | Sell |
| 200-day SMA: | 3.39 | Buy |
| 8-day EMA: | 3.5 | Sell |
| 20-day EMA: | 3.64 | Sell |
| 50-day EMA: | 3.77 | Sell |
| 200-day EMA: | 3.43 | Sell |
IONS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.5 | Buy |
| 20-day SMA: | 36.9 | Sell |
| 50-day SMA: | 38.54 | Sell |
| 200-day SMA: | 42.72 | Sell |
| 8-day EMA: | 35.21 | Buy |
| 20-day EMA: | 36.44 | Sell |
| 50-day EMA: | 38.7 | Sell |
| 200-day EMA: | 42.34 | Sell |
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Ionis Pharmaceuticals Earnings Growth & IONS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.03 per share.
Arbutus Biopharma Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ionis Pharmaceuticals Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||